Global Mucus Clearance Device Market, By Cycle Type (HFCWO Devices, OPEP Devices, MCA Devices, IPV Devices, PEP Devices), Indication (Cystic Fibrosis, COPD, Bronchiectasis, Others), End-User (Direct / Patient, Hospitals, Fertility Clinics and IVF Centres) – Industry Trends and Forecast to 2029.
Mucus Clearance Device Market Analysis and Size
According to the World Health Organization (WHO), COPD caused nearly 3.23 million deaths worldwide in 2019, making it the third leading cause of death worldwide. Moreover, the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases and the United Nations 2030 Agenda for Sustainable Development have both included this disease (NCDs). COPD cases are expected to rise in the near future, boosting sales of mucus clearance devices.
Data Bridge Market Research analyses that the mucus clearance device market which is expected to reach at a healthy CAGR of 6% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Mucus Clearance Device Market Scope and Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Million, Volumes in Units, Pricing in USD
Cycle Type (HFCWO Devices, OPEP Devices, MCA Devices, IPV Devices, PEP Devices), Indication (Cystic Fibrosis, COPD, Bronchiectasis, Others), End-User (Direct / Patient, Hospitals, Fertility Clinics and IVF Centres)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Hill-Rom Holdings, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Allergan (Ireland), Thayer Medical (U.S.), Electromed Inc. (U.S.), General Physiotherapy, Inc. (U.S.), VORTRAN Medical Technology 1 Inc. (U.S.), Monaghan (U.S.), PARI GmbH (Germany), Dymedso Inc. (Canada), Olympus Corporation (Japan), Medtronic (Ireland), Med Systems, Inc. (U.S.), Agilent Technologies, Inc. (U.S.)
Mucus clearance devices assist people with respiratory illnesses in clearing mucus-clogged airways. These devices are known to extend the lives of people suffering from critical illnesses such as COPD. In addition to exercise, it promises to significantly improve life quality. The mucus clearance devices market is expected to grow rapidly as it offers relief from a variety of respiratory illnesses such as Bronchitis, Atelectasis, Cystic Fibrosis, Asthma, and COPD, among others.
Global Mucus Clearance Device Market Dynamics
- Rising prevalence of COPD
The rising prevalence of asthma and chronic obstructive pulmonary disease (COPD) due to rising smoking rates, alpha-1 deficiency, second hand smoke exposure, air pollution, and chemical exposure is expected to drive demand for lung mucus clearance devices.
Furthermore, COPD frequently causes chest tightness, ankle swelling, wheezing, rapid weight loss, and shortness of breath.
- Surging cases of cystic fibrosis
The high prevalence of cystic fibrosis in China is expected to drive the mucus clearance devices market. Many educational and research institutions in China are also conducting extensive research and development to develop new treatment options for this condition.
Beijing Children's Hospital, for example, has begun a study to evaluate patients diagnosed with cystic fibrosis between the ages of 0 and 18 years. It would also look into the clinical information of recruited patients for ten years, such as clinical manifestations, quality of life, clinical manifestations, chest imaging clinical manifestations. As a result of the growing number of such research activities in China, novel lung mucus clearance devices will likely be developed.
- Rising geriatric population
The growing ageing population in the United Kingdom is expected to boost the mucus clearance device market. According to the United Kingdom Parliament, the number of older people in the country is expected to increase by 2043, with people aged 65 and up accounting for 24% of the population, while people aged 75 and up are expected to increase by 13% in 2043, up from 8% in 2018. Furthermore, the regulatory body in the United Kingdom's approval of various innovative lung clearing devices for the treatment of chronic respiratory illnesses is expected to drive the market.
- Dearth of awareness
Dearth of awareness in developing and under-developed regions is expected to restrain the growth of the mucus clearance device market during the forecast period off 2022-2029.
This mucus clearance device market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the mucus clearance device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- In January 2022, Life Wellness Healthcare, an Australian provider of medical devices for respiratory conditions, introduced its latest handheld Oscillating Positive Expiratory Pressure (OPEP) device called AirPhysio. It generates vibrations that loosen mucus and aid in the expansion of the lungs, making it easier to breathe. It is a drug-free device designed to keep atelectasis patients from developing severe symptoms.
- In December 2021, Respira Labs, a medtech company based in California, developed the Sylvee sensor adhesive patch. It is designed to be worn on the lower rib cage and can monitor respiratory health. It measures the amount of air trapped in the lungs as well as the volume of lung air. This data would assist healthcare professionals in determining whether a respiratory exacerbation is possible in patients.
Global Mucus Clearance Device Market Scope
The mucus clearance device market is segmented on the basis of cycle type, indication, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- HFCWO Devices
- OPEP Devices
- MCA Devices
- IPV Devices
- PEP Devices
- Cystic Fibrosis
- Direct / Patient
- Fertility Clinics
- IVF Centres
Mucus Clearance Device Market Regional Analysis/Insights
The mucus clearance device market is analyzed and market size insights and trends are provided by country, cycle type, indication, and end-user as referenced above.
The countries covered in the mucus clearance device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the mucus clearance device market due to the high prevalence of asthma and growing incidence of chronic pulmonary disease.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the high penetration of HFCWO and MCA devices owing to their increased use in treating respiratory diseases such as asthma and chronic cough respectively.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The mucus clearance device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for mucus clearance device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the mucus clearance device market. The data is available for historic period 2010-2020.
Competitive Landscape and Mucus Clearance Device Market Share Analysis
The mucus clearance device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to mucus clearance device market.
Some of the major players operating in the mucus clearance device market are:
- Hill-Rom Holdings, Inc. (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Allergan (Ireland)
- Thayer Medical (U.S.)
- Electromed Inc. (U.S.)
- General Physiotherapy, Inc. (U.S.)
- VORTRAN Medical Technology 1 Inc. (U.S.)
- Monaghan (U.S.)
- PARI GmbH (Germany)
- Dymedso Inc. (Canada)
- Olympus Corporation (Japan)
- Medtronic (Ireland)
- Med Systems, Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)